Display options
Share it on

Cartilage. 2015 Oct;6(4):233-40. doi: 10.1177/1947603515594453.

In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism.

Cartilage

Seth L Sherman, Ravand S Khazai, Christopher H James, Aaron M Stoker, David L Flood, James L Cook

Affiliations

  1. Department of Orthopaedic Surgery, University of Missouri, Columbia, MO, USA.
  2. Department of Orthopaedic Surgery, University of Chicago, Chicago, IL, USA.
  3. Comparative Orthopaedic Laboratory, University of Missouri, Columbia, MO, USA.
  4. Department of Orthopaedic Surgery, University of Missouri, Columbia, MO, USA ; Comparative Orthopaedic Laboratory, University of Missouri, Columbia, MO, USA.

PMID: 26425261 PMCID: PMC4568732 DOI: 10.1177/1947603515594453

Abstract

OBJECTIVE: There is growing concern that intra-articular injection of local anesthetic and/or corticosteroids may cause significant morbidity, including potential toxicity to chondrocytes and synoviocytes, after even a single exposure. We demonstrate that full thickness canine chondral and synovial samples exposed to various local anesthetics and corticosteroids exhibit decreased loss of cell viability compared with prior in vitro studies using monolayer culture, due to the protective effects of intact extracellular matrix and cell heterogeneity.

METHODS: Full-thickness cartilage and synovial explants were obtained from canine cadavers and exposed in culture media to the following for 24 hours: 1% lidocaine, 0.5% lidocaine, 0.25% bupivacaine, 0.125% bupvacaine, 0.0625% bupivacaine, betamethasone acetate, methylprednisolone acetate, triamcinolone acetonide, or culture media only (control). Cell viability was determined on days 1 and 7 of culture using a microscopic live-dead and alamar blue metabolic assays.

RESULTS: Complete loss of chondrocyte and synoviocyte viability was noted in the 1% and 0.5% lidocaine group, 0.25% and 0.125% bupivacaine group, betamethasone group, and methylprednisolone groups after 1 and 7 days of culture. Treatment with 0.0625% bupivacaine and triamcinolone demonstrated no decrease in cell viability or metabolism when compared to negative control.

CONCLUSIONS: In this canine explant model, 1% and 0.5% lidocaine, 0.25% and 0.125% bupivacaine, betamethasone acetate, and methylpresdnisolone acetate were severely chondrotoxic and synoviotoxic after a single exposure, despite intact extracellular matrix. In contrast, chondrocytes and synoviocytes exposed to 0.0625% bupivacaine and triamcinolone remained viable after treatment. Further in vivo study is needed before definitive recommendations can be made.

Keywords: chondrocyte; corticosteroid; local anesthetic; synoviocyte; toxicity

References

  1. Anesth Analg. 2013 Aug;117(2):514-22 - PubMed
  2. Cartilage. 2015 Apr;6(2):106-12 - PubMed
  3. Am J Sports Med. 2009 Jan;37(1):72-7 - PubMed
  4. Arthroscopy. 2009 Mar;25(3):225-31 - PubMed
  5. Arthroscopy. 2011 Feb;27(2):213-7 - PubMed
  6. Knee Surg Sports Traumatol Arthrosc. 2012 Nov;20(11):2294-301 - PubMed
  7. Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S66-79 - PubMed
  8. J Bone Joint Surg Am. 2010 Mar;92(3):609-18 - PubMed
  9. Clin Orthop Relat Res. 2011 Oct;469(10):2941-7 - PubMed
  10. J Bone Joint Surg Am. 2010 Mar;92(3):599-608 - PubMed
  11. Arthroscopy. 2006 Jul;22(7):693-9 - PubMed
  12. Bone Joint Res. 2014 Apr 02;3(4):89-94 - PubMed
  13. Am J Sports Med. 2010 Mar;38(3):520-6 - PubMed
  14. J Bone Joint Surg Br. 2008 Jun;90(6):814-20 - PubMed
  15. J Bone Joint Surg Am. 2008 May;90(5):986-91 - PubMed
  16. Knee Surg Sports Traumatol Arthrosc. 2013 Jun;21(6):1468-74 - PubMed
  17. Z Orthop Ihre Grenzgeb. 1996 Mar-Apr;134(2):144-8 - PubMed
  18. Am J Sports Med. 2012 Apr;40(4):794-9 - PubMed
  19. Am J Sports Med. 2011 Oct;39(10):2245-53 - PubMed
  20. Arthritis. 2012;2012:764621 - PubMed
  21. Clin Orthop Relat Res. 2010 Nov;468(11):3112-20 - PubMed

Publication Types